VOLUMEN 12 NÚMERO 1
PUBLICACION CUATRIMESTRAL
ENERO - ABRIL
2023
FACULTAD DE MEDICINA HUMANA “DANIEL ALCIDES CARRIÓN”
REVISTAS.UNICA.EDU.PE
INDEXADA EN:
PARANAZICA - Joaldo Torres Abanto Diagramador
REFERENCIAS BIBLIOGRÁFICAS
25
Rev méd panacea 2023 Ene-Abr;12(1): 23-25
Serna-Trejos Juan Santiago et al.
1.
2.
3.
4.
5.
6.
7.
8.
9.
Singal AK, Kodali S, Vucovich LA, Darley-Usmar V, Schiano
TD. Diagnosis and Treatment of Alcoholic Hepatitis: A
Systematic Review. Alcohol Clin Exp Res [Internet].
2016;40(7):1390–402. Available from:
doi:10.1111/acer.13108
Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M,
Mathurin P, et al. Standard Definitions and Common Data
Elements for Clinical Trials in Patients with Alcoholic
Hepatitis: Recommendation from the NIAAA Alcoholic
Hepatitis Consortia. Gastroenterology [Internet].
2016;150(4):785–90. Available from:
doi:10.1053/j.gastro.2016.02.042
Singal AK, Louvet A, Shah VH, Kamath PS. Grand Rounds:
Alcoholic Hepatitis. J Hepatol [Internet].
2018;69(2):534–43. Available from:
doi:10.1016/j.jhep.2018.05.001
University Virginia Commonwealth. Safety and Efficacy of
IMM 124-E for Patients With Severe Alcoholic Hepatitis
(TREAT). Clin Trials [Internet]. 2016; Available from:
https://clinicaltrials.gov/ct2/show/NCT01968382?term=N
CT01968382&rank=1
Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, et
al. Metagenomic Analyses of Alcohol Induced Pathogenic
Alterations in the Intestinal Microbiome and the Effect of
Lactobacillus rhamnosus GG Treatment. PLoS One
[Internet]. 2013;8(1):4–13. Available from:
doi:10.1371/journal.pone.0053028
Opal SM, Fisher CJ, Dhainaut JFA, Vincent JL, Brase R, Lowry
SF, et al. Confirmatory interleukin-1 receptor antagonist
trial in severe sepsis: A phase III, randomized, double-blind,
placebo-controlled, multicenter trial. Crit Care Med
[Internet]. 1997;25(7):1115–24. Available from:
doi:10.1097/00003246-199707000-00010
Frenette CT, Morelli G, Shiffman ML, Frederick RT, Rubin
RA, Fallon MB, et al. Emricasan Improves Liver Function in
Patients With Cirrhosis and High Model for End-Stage
Liver Disease Scores Compared With Placebo. Clin
Gastroenterol Hepatol [Internet]. 2019;17(4):774-783.e4.
Available from: doi:10.1016/j.cgh.2018.06.012
Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B,
et al. A Randomized, Double-Blinded, Placebo-Controlled
Multicenter Trial of Etanercept in the Treatment of
Alcoholic Hepatitis. Gastroenterology [Internet].
2008;135(6):1953–60. Available from:
doi:10.1053/j.gastro.2008.08.057
Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet
P, Piquet MA, et al. A Double-Blind Randomized Controlled
Trial of Infliximab Associated with Prednisolone in Acute
Alcoholic Hepatitis. Hepatology [Internet].
2004;39(5):1390–7. Available from: doi:10.1002/hep.20206
10.
11.
12.
Singal AK, Jampana SC, Weinman SA. Antioxidants as
therapeutic agents for liver disease. Liver Int [Internet].
2011;31(10):1432–48. Available from:
doi:10.1111/j.1478-3231.2011.02604.x
Higuera-De la Tijera F, Servín-Caamaño AI, Cruz-Herrera J,
Serralde-Zúñiga AE, Abdo-Francis JM, Gutiérrez-Reyes G,
et al. Treatment with metadoxine and its impact on early
mortality in patients with severe alcoholic Hepatitis. Ann
Hepatol [Internet]. 2014;13(3):343–52. Available from:
doi:10.1016/s1665-2681(19)30863-4
Singal AK, Shah VH. Current trials and novel therapeutic
targets for alcoholic hepatitis. J Hepatol [Internet].
2019;70(2):305–13. Available from:
doi:10.1016/j.jhep.2018.10.026
Cómo citar
Serna-Trejos Juan Santiago, Bermudez-Moyano Stefanya
Geraldine, Lenis-González Juan Pablo. Avances
terapéuticos en el manejo de la hepatitis alcohólica:
hallazgos prometedores. Rev méd panacea 2023;12(1):
23-25.
DOI: https://doi.org/10.35563/rmp.v12i1.518
Correspondencia:
Nombre: Juan Santiago Serna - Trejos
Correo electrónico: juansantiagosernatrejos@gmail.com
CARTA AL EDITOR